Trials / Completed
CompletedNCT02682849
Active Clearance Technology (ACT) Registry
Prevention of Retained-Blood Outcomes With Active Clearance Technology- The ACT Registry
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 500 (actual)
- Sponsor
- John M. Stulak · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the effectiveness of the PleuraFlow® Active Clearance Technology™ (ACT) System in the management of blood evacuation after cardiac surgery.
Conditions
Timeline
- Start date
- 2016-05-10
- Primary completion
- 2018-05-01
- Completion
- 2020-03-01
- First posted
- 2016-02-15
- Last updated
- 2020-10-29
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02682849. Inclusion in this directory is not an endorsement.